CC
WST icon

Courier Capital’s West Pharmaceutical WST Stock Holding History

Courier Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-592
Closed -$208K – 366
2023
Q4 		$208K Sell
592
-85
-13% -$30.1K 0.02% 342
2023
Q3 		$254K Sell
677
-75
-10% -$29K 0.02% 303
2023
Q2 		$288K Sell
752
-110
-13% -$39.3K 0.02% 305
2023
Q1 		$299K Sell
862
-60
-7% -$17.5K 0.03% 229
2022
Q4 		$217K Sell
922
-10
-1% -$2.37K 0.03% 270
2022
Q3 		$229K Buy
+932
New +$284K 0.03% 252

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Courier Capital's WST Position: Q1 2024 in Review

Courier Capital sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 592 shares — an estimated $208K sold.

Courier Capital first reported a position in WST in Q3 2022 and held it in 6 quarters. The position peaked at $299K in Q1 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Courier Capital reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Courier Capital sold 592 West Pharmaceutical shares in Q1 2024, an estimated $208K.
  • Courier Capital first reported a position in West Pharmaceutical in Q3 2022 and held it in 6 quarters.
  • Courier Capital's West Pharmaceutical position peaked at $299K in Q1 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Courier Capital's 13F filing for Q1 2024, filed 16 Apr 2024.